Book a free demo with us
Book Now
Pluri
Pluri is a global leader in 3D cell-expansion technology, developing platforms to manufacture the products and solutions of the future.
Total Fundraised$172.3M
Post-IPO Equity
Post-IPO Debt
Grant
2003
Haifa, Israel
ISR
Healthcare
Biotechnology
Biotech
Healthtech
3D Technology
Medical
-
Post-IPO Equity
https://pluri-biotech.com/Pluri's Stages
Post-IPO Equity
Grant
Post-IPO Debt
Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
Pluri's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|---|---|---|
Post-IPO Equity | 13 May 2010 | Undisclosed | 250K |
Post-IPO Equity | 13 Oct 2010 | Undisclosed | 1.2M |
Grant | 17 Jun 2015 | Office of the Chief Scientist | 2.9M 1 Investors |
Content Locked
Login or Register a FREE account to continue browsing our content
Related Startups
%2Fuploads%2Fpr%2520articles%2F2025%2F02%2F05_3pluri.jpg&w=3840&q=75)
%2Fuploads%2Fpr%2520articles%2F2024%2F06%2F20_3insightec.jpg&w=3840&q=75)
Social Media
© 2025 Lucidity Insights.
